These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34560169)

  • 41. Categorization framework to aid exposure assessment of nanomaterials in consumer products.
    Hansen SF; Michelson ES; Kamper A; Borling P; Stuer-Lauridsen F; Baun A
    Ecotoxicology; 2008 Jul; 17(5):438-47. PubMed ID: 18454314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opinion of the Scientific Committee on Consumer safety (SCCS)--Opinion on the safety of the use of α-arbutin in cosmetic products.
    Sccs ; Degen GH
    Regul Toxicol Pharmacol; 2016 Feb; 74():75-6. PubMed ID: 26646661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety assessment of a novel active ingredient, acetyl aspartic acid, according to the EU Cosmetics Regulation and the Scientific Committee on Consumer Safety guidelines.
    Daly P; Moran G
    Int J Cosmet Sci; 2015 Oct; 37 Suppl 1():21-7. PubMed ID: 26114401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Opinion of the Scientific Committee on consumer safety (SCCS) - Final opinion on the safety of fragrance ingredient Acetylated Vetiver Oil (AVO) - (Vetiveria zizanioides root extract acetylated) - Submission III.
    ;
    Regul Toxicol Pharmacol; 2019 Oct; 107():104389. PubMed ID: 31176744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Principles for the safety evaluation of cosmetic powders.
    Steiling W; Almeida JF; Assaf Vandecasteele H; Gilpin S; Kawamoto T; O'Keeffe L; Pappa G; Rettinger K; Rothe H; Bowden AM
    Toxicol Lett; 2018 Nov; 297():8-18. PubMed ID: 30125618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
    Pauwels M; Rogiers V
    Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current opinion on risk assessment of cosmetics.
    Kim KB; Kwack SJ; Lee JY; Kacew S; Lee BM
    J Toxicol Environ Health B Crit Rev; 2021 May; 24(4):137-161. PubMed ID: 33832410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A perspective on the safety of cosmetic products: a position paper of the American Council on Science and Health.
    Ross G
    Int J Toxicol; 2006; 25(4):269-77. PubMed ID: 16815815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nanomaterials and regulation of cosmetics.
    Bowman DM; van Calster G; Friedrichs S
    Nat Nanotechnol; 2010 Feb; 5(2):92. PubMed ID: 20130584
    [No Abstract]   [Full Text] [Related]  

  • 50. Consumer exposure to certain ingredients of cosmetic products: The case for tea tree oil.
    Rieder BO
    Food Chem Toxicol; 2017 Oct; 108(Pt A):326-338. PubMed ID: 28818687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. European Commission--Directorate General DG XXIV Consumer Policy and Consumer Health Protection. Notes of Guidance for testing of cosmetic ingredients for their safety evaluation (Second Revision). Adopted: 20 December 1996. Revised: 16 January 1997. The Scientific Committee on Cosmetology of the European Commission.
    Food Chem Toxicol; 1999 Apr; 37(4):357-85. PubMed ID: 10418954
    [No Abstract]   [Full Text] [Related]  

  • 52. Challenges in Nanomaterial Characterization - From Definition to Analysis.
    Catita JAM
    Adv Exp Med Biol; 2022; 1357():3-17. PubMed ID: 35583638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Screening of repeated dose toxicity data present in SCC(NF)P/SCCS safety evaluations of cosmetic ingredients.
    Vinken M; Pauwels M; Ates G; Vivier M; Vanhaecke T; Rogiers V
    Arch Toxicol; 2012 Mar; 86(3):405-12. PubMed ID: 22038139
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The way forward for assessing the human health safety of cosmetics in the EU - Workshop proceedings.
    Rogiers V; Benfenati E; Bernauer U; Bodin L; Carmichael P; Chaudhry Q; Coenraads PJ; Cronin MTD; Dent M; Dusinska M; Ellison C; Ezendam J; Gaffet E; Galli CL; Goebel C; Granum B; Hollnagel HM; Kern PS; Kosemund-Meynen K; Ouédraogo G; Panteri E; Rousselle C; Stepnik M; Vanhaecke T; von Goetz N; Worth A
    Toxicology; 2020 Apr; 436():152421. PubMed ID: 32119890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Don't define nanomaterials.
    Maynard AD
    Nature; 2011 Jul; 475(7354):31. PubMed ID: 21734686
    [No Abstract]   [Full Text] [Related]  

  • 56. [Cosmetic products : Safety aspects].
    Platzek T; Krätke R; Schulz C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jun; 53(6):610-4. PubMed ID: 20464352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Scientific Opinion on Risk Assessment of Synthetic Biology.
    Epstein MM; Vermeire T
    Trends Biotechnol; 2016 Aug; 34(8):601-603. PubMed ID: 27234301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human health safety evaluation of cosmetics in the EU: a legally imposed challenge to science.
    Pauwels M; Rogiers V
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):260-74. PubMed ID: 20006634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nanomaterials in Cosmetics: Recent Updates.
    Fytianos G; Rahdar A; Kyzas GZ
    Nanomaterials (Basel); 2020 May; 10(5):. PubMed ID: 32443655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Engineered inorganic nanoparticles and cosmetics: facts, issues, knowledge gaps and challenges.
    Wiechers JW; Musee N
    J Biomed Nanotechnol; 2010 Oct; 6(5):408-31. PubMed ID: 21329039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.